Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MINNEAPOLIS, MINNESOTA--(Marketwired - April 28, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF), announces the completion of the issuance of shares in settlement of...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - April 18, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA) (OTCQB:DMCAF), is pleased to announce that, effective April 11, 2016, it has been...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - April 11, 2016) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF) (the "Company"), today announced that the Company will be presenting at the 2016 BFC...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - March 10, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF), announces its intention to issue 50,000 shares at a deemed price of...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - March 1, 2016) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF) (the "Company") is pleased to announce the engagement of JV Public Relations New York...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Feb. 25, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF), announced today the closing of $140,000 in a second tranche which...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Feb. 18, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) announced today the closing of $610,000 in the first tranche of its...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Feb. 5, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF), announces that, subject to TSX Venture Exchange ("TSXV") approval, it...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Feb. 2, 2016) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF) (the "Company") a clinical-stage biotechnology company focused on developing novel...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Jan. 20, 2016) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF) ("DiaMedica"), today announced the appointment of Dr. Todd Verdoorn as DiaMedica's...